Za, Tommaso
 Distribuzione geografica
Continente #
NA - Nord America 1.979
EU - Europa 1.438
AS - Asia 1.137
SA - Sud America 184
Continente sconosciuto - Info sul continente non disponibili 44
AF - Africa 25
OC - Oceania 4
Totale 4.811
Nazione #
US - Stati Uniti d'America 1.936
DE - Germania 542
SG - Singapore 538
CN - Cina 327
SE - Svezia 268
BR - Brasile 145
FR - Francia 140
IT - Italia 113
UA - Ucraina 110
VN - Vietnam 97
GB - Regno Unito 83
IE - Irlanda 55
ID - Indonesia 32
IN - India 31
RU - Federazione Russa 27
FI - Finlandia 26
PL - Polonia 22
JP - Giappone 20
CA - Canada 18
HK - Hong Kong 18
AR - Argentina 16
BE - Belgio 15
TR - Turchia 14
BD - Bangladesh 11
SA - Arabia Saudita 9
AT - Austria 7
CO - Colombia 7
IQ - Iraq 7
MX - Messico 7
ES - Italia 6
NL - Olanda 6
VE - Venezuela 6
JM - Giamaica 5
PH - Filippine 5
ZA - Sudafrica 5
CI - Costa d'Avorio 4
EC - Ecuador 4
JO - Giordania 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CL - Cile 3
GT - Guatemala 3
HU - Ungheria 3
IR - Iran 3
KE - Kenya 3
PK - Pakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
KR - Corea 2
LT - Lituania 2
MY - Malesia 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
UZ - Uzbekistan 2
BB - Barbados 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
KZ - Kazakistan 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
WS - Samoa 1
ZW - Zimbabwe 1
Totale 4.770
Città #
Singapore 298
Chandler 274
San Jose 141
Ashburn 138
Jacksonville 79
Nanjing 70
Dearborn 58
San Mateo 55
Beijing 54
Dublin 53
Los Angeles 51
Ann Arbor 42
Dallas 41
Munich 39
Ho Chi Minh City 34
Jakarta 30
Marseille 30
New York 30
Wilmington 30
Nanchang 28
Hanoi 27
Lauterbourg 27
Cattolica 24
Milan 23
Boston 22
Frankfurt am Main 20
Houston 20
Lawrence 20
Woodbridge 20
Council Bluffs 19
Nürnberg 19
Redwood City 19
Buffalo 16
Brussels 15
Kraków 15
Atlanta 14
Hefei 14
Fairfield 13
Hong Kong 13
Kunming 12
Lancaster 12
Orem 12
Tianjin 12
Tokyo 12
Hangzhou 11
Santa Clara 11
São Paulo 11
Moscow 10
Seattle 10
Detroit 9
Norwalk 9
Princeton 9
Shenyang 9
Boardman 8
Hebei 8
Brooklyn 7
Düsseldorf 7
Leawood 7
University Park 7
Belo Horizonte 6
Bremen 6
Chicago 6
Mountain View 6
Paris 6
Rio de Janeiro 6
Shanghai 6
Toronto 6
Ankara 5
Buenos Aires 5
Guangzhou 5
Haiphong 5
Izmir 5
Kent 5
London 5
Manchester 5
North Bergen 5
Phoenix 5
Piscataway 5
Portsmouth 5
Rome 5
Simi Valley 5
Abidjan 4
Amman 4
Campinas 4
Changsha 4
Da Nang 4
Johannesburg 4
Juiz de Fora 4
Kingston 4
Mexico City 4
Naples 4
Poplar 4
Redmond 4
St Louis 4
Vladivostok 4
Calgary 3
Changchun 3
Charlotte 3
Chennai 3
Des Moines 3
Totale 2.317
Nome #
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 454
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 379
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 207
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 179
Venous thromboembolism in multiple myeloma 175
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 169
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 168
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 168
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 167
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 160
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 157
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 154
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 153
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 150
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 149
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 147
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 145
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 144
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome 142
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 141
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 141
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy 140
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 137
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 134
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 125
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 112
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 110
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 107
The interaction between small intestinal bacterial overgrowth and warfarin treatment 97
Totale 4.811
Categoria #
all - tutte 17.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022286 0 0 0 12 16 6 5 43 14 22 72 96
2022/2023711 113 118 71 103 46 73 54 46 61 4 14 8
2023/2024225 10 77 3 7 4 28 3 19 4 13 27 30
2024/2025470 10 18 30 20 65 6 8 22 74 51 87 79
2025/20261.280 180 31 68 102 266 93 222 60 93 89 31 45
2026/2027420 33 270 84 33 0 0 0 0 0 0 0 0
Totale 4.811